Botwood Nicholas A.J., Head of R&D and CMO at Syndax Pharmaceuticals ($SNDX), made one open market purchase of company shares in the last year, totaling about $106 thousand. His most recent buy occurred on May 16, 2025. Among nearly 5,000 insiders tracked for purchases, his activity ranks 2090th by amount, below the average of $1.46 million across 3.29 transactions per insider. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Botwood Nicholas A.J. | Head of R&D, CMO | A | Common Stock | 24000 | $0.00 | 59,165.0000 | 86,914,838 | 68.25% | 0.03% |
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Botwood Nicholas A.J. | Head of R&D, CMO | A | Common Stock | 36000 | $0.00 | 95,165.0000 | 86,914,838 | 60.85% | 0.04% |
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Botwood Nicholas A.J. | Head of R&D, CMO | A | Stock Options (Right to buy) | 144700 | $20.43 | 144,700.0000 | 86,914,838 | 9999.99% | 0.17% |
| May 16, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Botwood Nicholas A.J. | Head of R&D, CMO | P | Common Stock | 11765 | $9.00 | 35,165.0000 | 86,024,394 | 50.28% | 0.01% |